Rznomics KRX:476830KOSDAQ

알지노믹스 · Korean news coverage and regulatory filings, organized.

Articles, 24h2
Articles, 7 days2
DART filings, 7 days1
Articles tracked2since Sep 11

In Q2 2026, Rznomics reported revenue of ₩808m and an operating loss of ₩6.9bn. Rznomics (알지노믹스) appeared in 2 Korean news articles and 1 DART filing over the past seven days. Coverage peaked on Sep 14 with 1 article.

Rznomics quarterly results separate, KRW

QuarterOperating profitNet income
Q2 2026−₩6.9bn−₩6.4bn
Q1 2026−₩8.1bn−₩7.8bn
Q4 2025 derived−₩5.4bn−₩5.3bn
Q3 2025−₩8.1bn−₩8.1bn
Q2 2025₩3.1bn−₩85.1bn
Q1 2025−₩4.1bn−₩5.3bn
Q4 2024 derived−₩2.6bn−₩5.6bn
Q3 2024−₩3.4bn−₩4.4bn

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases.

Rznomics top stories 2 weeks, by number of outlets

  1. 1
    알지노믹스 "RNA 플랫폼 수출 확대"
    1 outlets · 1 articlesFirst report Sep 14 17:29 한국경제
  2. 2
    알지노믹스 “RNA 치환, 나쁜 RNA 없애고 정상 RNA로 바꾼다”
    1 outlets · 1 articlesFirst report Sep 15 09:09 한국경제

Latest Rznomics news Korean headlines